Tirzepatide, a recently approved medication, is creating considerable excitement within the healthcare community. It works differently from existing diabetes therapies , targeting both receptors involved in sugar regulation and appetite . Initial studies have demonstrated significant efficacy in controlling blood glucose in individuals with type 2